Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Page 1
COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation-A Single-Center Study.
Souan L, Abdel-Razeq H, Nashwan S, Al Badr S, Alrabi K, Sughayer MA. Souan L, et al. Among authors: abdel razeq h. Vaccines (Basel). 2023 Oct 30;11(11):1659. doi: 10.3390/vaccines11111659. Vaccines (Basel). 2023. PMID: 38005991 Free PMC article.
CONCLUSIONS: COVID-19 vaccines can still induce a humoral immune response in patients undergoing cancer-targeted therapy. The strength of this study is the long-term monitoring of antibody levels after vaccination in cancer patients on active therapy using two different im …
CONCLUSIONS: COVID-19 vaccines can still induce a humoral immune response in patients undergoing cancer-targeted therapy. The strength of th …
Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients.
Al-Ibraheem A, Al-Rasheed U, Mashhadani N, Abdlkadir AS, Al-Adhami DA, Ruzzeh S, Istatieh F, Mansour A, Hamdan B, Kheetan R, Al-Shatti M, Mohamad I, Juweid ME, Abu Sheikha A, Al-Rabi K, Sykiotis GP, Kreissl MC, Ismael T, Sultan I, Abdel-Razeq H. Al-Ibraheem A, et al. Among authors: abdel razeq h. Cancers (Basel). 2023 Aug 15;15(16):4102. doi: 10.3390/cancers15164102. Cancers (Basel). 2023. PMID: 37627130 Free PMC article.
Extramedullary acute myeloid leukemia (eAML): Retrospective single center cohort study on clinico-pathological, molecular analysis and survival outcomes.
Halahleh K, Alhalaseh Y, Al-Rimawi D, Da'na W, Alrabi K, Kamal N, Muradi I, Abdel-Razeq H. Halahleh K, et al. Among authors: abdel razeq h. Ann Med Surg (Lond). 2021 Oct 22;72:102894. doi: 10.1016/j.amsu.2021.102894. eCollection 2021 Dec. Ann Med Surg (Lond). 2021. PMID: 34815855 Free PMC article.
Allotransplant in first complete remission may be the most effective modality for achieving long-term remissions....
Allotransplant in first complete remission may be the most effective modality for achieving long-term remissions....
Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives.
Falanga A, Gal GL, Carrier M, Abdel-Razeq H, Ay C, Martin AJM, Rocha ATC, Agnelli G, Elalamy I, Brenner B. Falanga A, et al. Among authors: abdel razeq h. TH Open. 2021 Aug 31;5(3):e376-e386. doi: 10.1055/s-0041-1736037. eCollection 2021 Jul. TH Open. 2021. PMID: 34485812 Free PMC article.
Increased risk of recurrent VTE and bleeding complications are two major challenges associated with therapeutic anticoagulation in these patients. Long-term therapy with low-molecular-weight heparins (LMWHs) has been the standard of care for the treatment of cancer-associa …
Increased risk of recurrent VTE and bleeding complications are two major challenges associated with therapeutic anticoagulation in these pat …
Amenorrhea, fertility preservation, and counseling among young women treated with anthracyclines and taxanes for early-stage breast cancer, a retrospective study.
Abdel-Razeq HN, Mansour RA, Ammar KS, Abdel-Razeq RH, Zureigat HY, Yousef LM, Shahin OA. Abdel-Razeq HN, et al. Medicine (Baltimore). 2020 Mar;99(11):e19566. doi: 10.1097/MD.0000000000019566. Medicine (Baltimore). 2020. PMID: 32176115 Free PMC article.
Seventy-nine (85.9%) respondents were counseled about amenorrhea and 37 (40.2%) were considering having children. Long-term amenorrhea was reported by 51 (54.3%) patients. The addition of taxanes to anthracyclines, in 2 different regimens, increased the risk of amenorrhea …
Seventy-nine (85.9%) respondents were counseled about amenorrhea and 37 (40.2%) were considering having children. Long-term amenorrhe …
Clinicopathological Characteristics And Treatment Outcomes Of Breast Cancer Among Adolescents And Young Adults In A Developing Country.
Abdel-Razeq H, Almasri H, Abdel Rahman F, Abdulelah H, Abu Nasser M, Salam M, Al-Dairi A, Natour O, Rimawi D. Abdel-Razeq H, et al. Cancer Manag Res. 2019 Nov 22;11:9891-9897. doi: 10.2147/CMAR.S229337. eCollection 2019. Cancer Manag Res. 2019. PMID: 31819626 Free PMC article.
Breast cancer in younger patients tends to be more aggressive, and may result in a higher likelihood of long-term treatment-related toxicity and unique psychosocial problems. ...
Breast cancer in younger patients tends to be more aggressive, and may result in a higher likelihood of long-term treatment-related t …
Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve.
Abdel-Razeq H. Abdel-Razeq H. Ann Thorac Med. 2010 Oct;5(4):195-200. doi: 10.4103/1817-1737.69104. Ann Thorac Med. 2010. PMID: 20981179 Free PMC article.
Although most patients survive DVT, they often develop serious and costly long-term complications. Both unfractionated heparin and low molecular weight heparins significantly reduce the incidence of VTE and its associated complications. ...
Although most patients survive DVT, they often develop serious and costly long-term complications. Both unfractionated heparin and lo …
Ximelagatran, the new oral anticoagulant: would warfarin survive the challenge?
Mousa SA, Abdel-Razeq HN. Mousa SA, et al. Among authors: abdel razeq hn. Cardiovasc Drug Rev. 2005 Winter;23(4):331-44. doi: 10.1111/j.1527-3466.2005.tb00176.x. Cardiovasc Drug Rev. 2005. PMID: 16614732 Review.
Ximelagatran has been approved, however, by the European regulatory authorities for short-term thromboprophylaxis. The success of ximelagatran or other oral antithrombin agents would provide significant proof of the concept for the long-term use of oral antithrombin …
Ximelagatran has been approved, however, by the European regulatory authorities for short-term thromboprophylaxis. The success of xim …